Attached files
| file | filename |
|---|---|
| EX-32.2 - AIM ImmunoTech Inc. | ex32-2.htm |
| EX-32.1 - AIM ImmunoTech Inc. | ex32-1.htm |
| EX-31.2 - AIM ImmunoTech Inc. | ex31-2.htm |
| EX-31.1 - AIM ImmunoTech Inc. | ex31-1.htm |
| EX-21 - AIM ImmunoTech Inc. | ex-21.htm |
| 10-K - AIM ImmunoTech Inc. | form10-k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Hemispherx Biopharma, Inc.
Philadelphia, Pennsylvania
We consent to the incorporation by reference in Registration Statements (No. 333-160499, 333-57134, 118903, 333-155528 and 333-209060) on Form S-8 and Registration Statements (No. 333-182216, 333-152727, 333-126804, 333-130008, 333-159856, 333-151696 and 333-205228) on Form S-3 of Hemispherx Biopharma, Inc. and Subsidiaries of our report dated March 31, 2017 relating to our audit of the consolidated financial statements which appears in this Annual Report on Form 10-K of Hemispherx Biopharma, Inc. for the year ended December 31, 2016.
| /s/ RSM US LLP | |
| RSM US LLP | |
| Blue Bell, Pennsylvania | |
| March 31, 2017 |